BRKR

Bruker Corporation NASDAQ

Healthcare ·Medical - Devices ·US · bruker.com

$36.39

Mkt Cap $5.5B

52w Low $28.53 28.4% of range 52w High $56.22

50d MA $37.13 200d MA $39.51

P/E (TTM) -245.3x

EV/EBITDA 30.9x

P/B 2.2x

Debt/Equity 0.8x

ROE -0.4%

P/FCF 165.2x

RSI (14) —

ATR (14) —

Beta 1.20

50d MA $37.13

200d MA $39.51

Avg Volume 2.2M

About

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science ma…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 12, 2026	AMC	0.65	0.59	-9.2%	37.51	-1.5%	-2.7%	+1.6%	+6.0%	+3.3%	+2.1%	-12.7%	—
Nov 3, 2025	AMC	0.33	0.60	+81.8%	38.71	-0.2%	+4.3%	+3.8%	+1.6%	+3.2%	+5.3%	+23.6%	—
Aug 4, 2025	AMC	0.33	0.32	-3.0%	34.72	+0.2%	-7.6%	-11.7%	-10.3%	-12.4%	-11.3%	-15.5%	—
May 7, 2025	AMC	0.46	0.47	+2.2%	40.76	-0.6%	-0.6%	-7.9%	-1.2%	-5.0%	-9.6%	-6.0%	—
Feb 13, 2025	AMC	0.75	0.76	+1.3%	51.15	+0.7%	-2.2%	-0.8%	+0.8%	+3.5%	-0.6%	-8.2%	—
Nov 5, 2024	AMC	0.61	0.60	-1.6%	61.34	+0.7%	-3.8%	-1.4%	-5.9%	-7.6%	-8.7%	-4.7%	—
Aug 6, 2024	AMC	0.52	0.52	+0.0%	62.16	+1.9%	-3.0%	+1.9%	-0.3%	-2.8%	-1.3%	+5.1%	—
May 2, 2024	AMC	0.46	0.53	+15.2%	70.09	+0.9%	-0.1%	+3.5%	+6.0%	+5.2%	+8.7%	-8.0%	—
Feb 13, 2024	AMC	0.65	0.70	+7.7%	76.79	+2.6%	+4.2%	+4.3%	+6.6%	+5.6%	+6.7%	+19.6%	—
Nov 2, 2023	AMC	0.63	0.74	+17.5%	56.41	+0.2%	+4.3%	-0.5%	+3.3%	+2.3%	+1.5%	+17.7%	—
Aug 3, 2023	AMC	0.49	0.50	+2.0%	67.52	-0.7%	-1.9%	-1.1%	-2.9%	-2.7%	-1.7%	-5.3%	—
May 4, 2023	AMC	0.55	0.64	+16.4%	81.58	+0.6%	-3.7%	-5.4%	-6.5%	-7.1%	-6.2%	-10.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Barclays	Maintains	Overweight → Overweight	—	$39.90	$39.90	+0.0%	-1.1%	-2.4%	+2.0%	+3.0%	+0.5%
Apr 14	Barclays	Maintains	Overweight → Overweight	—	$39.05	$39.54	+1.3%	+2.2%	+1.1%	-0.3%	+4.2%	+5.2%
Mar 30	Guggenheim	Maintains	Buy → Buy	—	$33.72	$33.41	-0.9%	+1.7%	+7.1%	+7.0%	+9.0%	+9.0%
Feb 13	Citigroup	Maintains	Neutral → Neutral	—	$37.51	$36.94	-1.5%	-2.7%	+1.6%	+6.0%	+3.3%	+2.1%
Feb 13	Barclays	Maintains	Overweight → Overweight	—	$37.51	$36.94	-1.5%	-2.7%	+1.6%	+6.0%	+3.3%	+2.1%
Feb 13	Goldman Sachs	Maintains	Sell → Sell	—	$37.51	$36.94	-1.5%	-2.7%	+1.6%	+6.0%	+3.3%	+2.1%
Feb 13	TD Cowen	Maintains	Hold → Hold	—	$37.51	$36.94	-1.5%	-2.7%	+1.6%	+6.0%	+3.3%	+2.1%
Jan 26	Guggenheim	Maintains	Buy → Buy	—	$50.33	$49.75	-1.2%	-3.8%	-5.3%	-7.5%	-12.1%	-12.0%
Jan 16	Citigroup	Maintains	Neutral → Neutral	—	$49.46	$49.45	-0.0%	-2.2%	+0.8%	+5.0%	+5.4%	+1.8%
Jan 7	TD Cowen	Maintains	Hold → Hold	—	$52.67	$52.17	-0.9%	+0.6%	-0.4%	+3.4%	+1.4%	-3.4%
Jan 5	Guggenheim	Maintains	Buy → Buy	—	$48.11	$48.06	-0.1%	+6.5%	+9.5%	+10.2%	+9.1%	+13.2%
Dec 15	JP Morgan	Maintains	Overweight → Overweight	—	$45.13	$46.34	+2.7%	+1.2%	-0.4%	-1.6%	-1.0%	+3.0%
Dec 15	Barclays	Maintains	Overweight → Overweight	—	$45.13	$46.34	+2.7%	+1.2%	-0.4%	-1.6%	-1.0%	+3.0%
Dec 15	Wells Fargo	Maintains	Overweight → Overweight	—	$45.13	$46.34	+2.7%	+1.2%	-0.4%	-1.6%	-1.0%	+3.0%
Dec 15	BofA Securities	Maintains	Buy → Buy	—	$45.13	$46.34	+2.7%	+1.2%	-0.4%	-1.6%	-1.0%	+3.0%
Dec 10	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$45.36	$46.83	+3.2%	+3.4%	+2.2%	-0.5%	+0.7%	-0.9%
Nov 5	Wells Fargo	Maintains	Overweight → Overweight	—	$40.38	$39.45	-2.3%	-0.4%	-2.6%	-1.1%	+1.0%	+3.3%
Nov 4	UBS	Maintains	Neutral → Neutral	—	$38.71	$38.63	-0.2%	+4.3%	+3.8%	+1.6%	+3.2%	+5.3%
Nov 4	Barclays	Maintains	Overweight → Overweight	—	$38.71	$38.63	-0.2%	+4.3%	+3.8%	+1.6%	+3.2%	+5.3%
Nov 4	TD Cowen	Maintains	Hold → Hold	—	$38.71	$38.63	-0.2%	+4.3%	+3.8%	+1.6%	+3.2%	+5.3%
Oct 2	Barclays	Maintains	Overweight → Overweight	—	$34.72	$34.86	+0.4%	+0.3%	+6.5%	+5.0%	-0.5%	-0.3%
Aug 5	Stifel	Maintains	Hold → Hold	—	$34.72	$34.80	+0.2%	-7.6%	-11.7%	-10.3%	-12.4%	-11.3%
Aug 5	Wells Fargo	Maintains	Overweight → Overweight	—	$34.72	$34.80	+0.2%	-7.6%	-11.7%	-10.3%	-12.4%	-11.3%
Aug 4	Citigroup	Maintains	Neutral → Neutral	—	$37.99	$34.13	-10.2%	-8.6%	-15.6%	-19.3%	-18.0%	-19.9%
Aug 4	Jefferies	Maintains	Buy → Buy	—	$37.99	$34.13	-10.2%	-8.6%	-15.6%	-19.3%	-18.0%	-19.9%
Aug 4	Barclays	Maintains	Overweight → Overweight	—	$37.99	$34.13	-10.2%	-8.6%	-15.6%	-19.3%	-18.0%	-19.9%
Jun 26	BofA Securities	Maintains	Buy → Buy	—	$40.93	$40.94	+0.0%	+3.1%	+2.1%	+0.7%	+2.4%	+3.7%
May 22	Citigroup	Downgrade	Buy → Neutral	—	$36.45	$35.75	-1.9%	-0.3%	-2.6%	+1.9%	+1.4%	+2.2%
May 8	Stifel	Maintains	Hold → Hold	—	$40.76	$40.51	-0.6%	-0.6%	-7.9%	-1.2%	-5.0%	-9.6%
May 8	UBS	Maintains	Neutral → Neutral	—	$40.76	$40.51	-0.6%	-0.6%	-7.9%	-1.2%	-5.0%	-9.6%
May 8	Barclays	Maintains	Overweight → Overweight	—	$40.76	$40.51	-0.6%	-0.6%	-7.9%	-1.2%	-5.0%	-9.6%
May 8	Goldman Sachs	Maintains	Neutral → Neutral	—	$40.76	$40.51	-0.6%	-0.6%	-7.9%	-1.2%	-5.0%	-9.6%
Apr 17	Wells Fargo	Maintains	Overweight → Overweight	—	$37.74	$37.11	-1.7%	-3.9%	-4.7%	-2.1%	+0.4%	+3.3%
Apr 10	Barclays	Maintains	Overweight → Overweight	—	$41.19	$40.02	-2.8%	-7.6%	-5.9%	-3.0%	-6.7%	-8.4%
Apr 7	Citigroup	Maintains	Buy → Buy	—	$36.46	$35.55	-2.5%	+6.1%	-0.3%	+13.0%	+4.4%	+6.3%
Feb 24	Guggenheim	Maintains	Buy → Buy	—	$50.82	$50.45	-0.7%	+2.1%	+0.3%	-0.6%	-6.0%	-7.1%
Feb 14	Stifel	Maintains	Hold → Hold	—	$51.15	$51.50	+0.7%	-2.2%	-0.8%	+0.8%	+3.5%	-0.6%
Feb 14	Barclays	Maintains	Overweight → Overweight	—	$51.15	$51.50	+0.7%	-2.2%	-0.8%	+0.8%	+3.5%	-0.6%
Feb 10	Barclays	Maintains	Overweight → Overweight	—	$55.59	$54.00	-2.9%	-8.0%	-8.9%	-7.1%	-8.0%	-10.0%
Jan 17	Guggenheim	Maintains	Buy → Buy	—	$59.01	$59.58	+1.0%	-3.6%	+1.8%	+1.9%	-1.4%	-2.9%
Dec 13	BofA Securities	Maintains	Buy → Buy	—	$58.52	$58.57	+0.1%	-1.4%	-2.3%	-1.2%	-5.4%	-5.5%
Dec 5	Goldman Sachs	Upgrade	Sell → Neutral	—	$59.50	$59.95	+0.8%	-1.7%	-0.9%	+3.3%	+0.8%	+0.3%
Nov 6	Citigroup	Maintains	Buy → Buy	—	$61.34	$61.80	+0.7%	-3.8%	-1.4%	-5.9%	-7.6%	-8.7%
Nov 6	TD Cowen	Maintains	Hold → Hold	—	$61.34	$61.80	+0.7%	-3.8%	-1.4%	-5.9%	-7.6%	-8.7%
Nov 6	Wells Fargo	Maintains	Overweight → Overweight	—	$61.34	$61.80	+0.7%	-3.8%	-1.4%	-5.9%	-7.6%	-8.7%
Nov 6	Barclays	Maintains	Overweight → Overweight	—	$61.34	$61.80	+0.7%	-3.8%	-1.4%	-5.9%	-7.6%	-8.7%
Sep 30	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$70.67	$69.46	-1.7%	-2.3%	-5.5%	-4.5%	-6.9%	-5.2%
Aug 7	TD Cowen	Maintains	Hold → Hold	—	$62.16	$63.31	+1.9%	-3.0%	+1.9%	-0.3%	-2.8%	-1.3%
Jul 10	Citigroup	Maintains	Buy → Buy	—	$61.21	$61.55	+0.6%	+0.1%	+4.1%	+5.8%	+3.6%	+8.2%
Jul 9	Goldman Sachs	Maintains	Sell → Sell	—	$62.20	$62.37	+0.3%	-1.6%	-1.5%	+2.4%	+4.1%	+1.9%

Recent Filings

8-K · 5.02 !!! Very High

Mesa Laboratories Inc -- 8-K 5.02: Executive Change

Mesa Laboratories appoints Dr. Siddhartha Kadia as President following Owens' resignation, signaling leadership transition that investors should monitor for strategic direction changes.

Mar 9

8-K · 5.02 !!! Very High

Bruker Corporation -- 8-K 5.02: Executive Change

Jack Phillips resigned from Bruker Corporation's board, creating a vacancy in the Class II director position that requires replacement.

Feb 20

8-K

Bruker Corporation -- 8-K Filing

Bruker Corporation exceeded fourth-quarter revenue expectations despite 2025 headwinds from academic funding cuts, tariffs, and currency challenges, signaling resilience in its core business.

Feb 12

Data updated apr 24, 2026 10:48pm · Source: massive.com